Rosacea in ophthalmological and dermatovenerologic practice. Clinical cases
https://doi.org/10.21516/2072-0076-2025-18-1-104-109
Abstract
Rosacea is a chronic inflammatory disease that can manifest itself with various clinical symptoms. It is mainly a skin disease, but the eyes, including the eyelids, cornea and conjunctiva, can also be affected. Due to the variety of clinical manifestations of rosacea, including ocular forms, varying severity of the pathological process, as well as insufficient understanding of its etiology and pathogenesis, there are currently no universal treatment regimens. The purpose of the work is to substantiate a multidisciplinary approach to the treatment of this disease. Material and methods. This article considers the role of the Demodex mite in the development of the disease, various variants of its clinical manifestation, approaches to treatment, and two clinical cases. Results. The main treatment includes the use of both systemic and local drugs. In the treatment of ocular forms of the disease, in addition to systemic treatment, local agents are used, such as artificial tears, anti-inflammatory drugs and immunosuppressants. In cases of severe corneal damage, various types of keratoplasty may be required. Conclusion. To determine the most effective treatment strategy for cutaneous and ocular rosacea, collaboration between ophthalmologists and dermatologists is necessary.
About the Authors
P. E. Arsenyev
Clinical hospital “Russian Railways — Medicine”
Russian Federation
Russian Federation
Pavel E. Arsenyev — ophthalmologist.
12, Agibalova St., Samara, 443041
E. V. Orlov
Samara State Medical University
Russian Federation
Russian Federation
Evgeny V. Orlov — Dr. of Med. Sci., professor of chair of dermatovenerology and cosmetology.
89, Chapaevskaya St., Samara, 443099
A. A. Arsenyeva
Samara State Medical University
Russian Federation
Russian Federation
Antonina A. Arsenyeva — Cand. of Med. Sci., associate professor of chair of dermatovenerology and cosmetology.
89, Chapaevskaya St., Samara, 443099
Yu. M. Pakhomova
Samara State Medical University
Russian Federation
Russian Federation
Yulia M. Pakhomova — assistant professor of chair of dermatovenerology and cosmetology.
89, Chapaevskaya St., Samara, 443099
References
1. Arlt F. Ueber Acne Rosacea und Lupus. Klin Monatsbl Augenheilkd. 1864; 2: 329–30.
2. Wise G. Ocular rosacea. American Journal of Ophthalmology. 1943; 26: 591–609.
3. Keles H, Yuksel EH, Aydin F, Senturk N. Pre-treatment and post-treatment demodex densities in patients under immunosuppressive treatments. Medicina (Kaunas). 2020; 56 (3): 107–9. doi: 10.3390/medicina56030107
4. Trufanov S.V., Shakhbazyan N.P. Ophthalmic Rosacea: etiopathogenesis and modern treatment methods. Vestnik Oftal’mologii. 2018; 134 (3): 121–8 (In Russ.). https://doi.org/10.17116/oftalma20181343121
5. Lacey N, Russell-Hallinan А, Zoubouli СС, Powell FC. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea. Br J Dermatol. 2018; 179: 252–3. doi:10.1111/bjd.16540
6. Ahmed NS, El-Fattah El-Nadi NA, Abd Elmaged WM, Ali EO. Relationship between Demodex spp. infestation and acne disease. Sohag Medical J. 2021; 25 (2): 1–6. doi:10.21608/smj.2021.61513.1224
7. Cheng AM, Hwang J, Dermer H, Galor A. Prevalence of ocular demodicosis in an older population and its association with symptoms and signs of dry eye. Cornea. 2021; 40: 995–1001. doi:10.1097/ICO.0000000000002542
8. Forton FMN. The pathogenic role of Demodex mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea? Dermatol Ther. 2020; 10 (6): 1229–53. doi:10.1007/s13555-020-00458-9
9. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953 Dec;65(12):458-63. doi: 10.1111/j.1365-2133.1953.tb13185.x
10. Biernat MM, Rusiecka-Ziolkowska J, Piatkowska E, et al. Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study. Jpn J Ophthalmol. 2018; 62 (6): 628–33. doi: 10.1007/s10384-018-0624-3
11. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 Jan; 78 (1): 148–55. doi: 10.1016/j.jaad.2017.08.037
12. Kaya OA, Akkucuk S, Ilhan G, et al. The importance of Demodex mites (Acari: Demodicidae) in patients with sickle cell anemia. J Med Entomol. 2019; 56 (3): 599–602. doi: 10.1093/jme/tjy225
13. Chuprov A.D., Malgina E.K. The modern view of foreign authors on the diagnosis and treatment of blepharitis of demodectic etiology. Practical medicine. 2018; 114 (3): 200–3 (In Russ.).
14. Yusupova L.A. The current state of the problem of exfoliative dermatitis. Lechaschi Vrach. 2019; 11: 6–8 (In Russ.). doi: 10.26295/OS.2019.43.24.001
15. Samtsov A.V. The evolution of ideas about rosacea. Opinion Leader. 2020; 10: 52–8 (In Russ.).
16. Pustovaya K.N., Piavchenko G.A., Arisov M.V., Nozdrin V.I. Individual motility and acarogram ascriteria for evaluating the effect of drugs against ticks of the genus Demodex. Russian journal of clinical dermatology and venereology. 2019; 18 (6): 710–4 (In Russ.). https://doi.org/10.17116/klinderma201918061710
17. Federal Clinical guidelines for the management of rosacea patients. Russian Society of Dermatovenerologists and Cosmetologists. 2015 (In Russ.).
Review
For citations:
Arsenyev P.E., Orlov E.V., Arsenyeva A.A., Pakhomova Yu.M. Rosacea in ophthalmological and dermatovenerologic practice. Clinical cases. Russian Ophthalmological Journal. 2025;18(1):104-109. (In Russ.) https://doi.org/10.21516/2072-0076-2025-18-1-104-109
Views:
123
Email this article 